Field Medical and CardioNXT announced a strategic collaboration to provide what they say is a first-of-its-kind pulsed-field ablation (PFA) therapy.
The two companies plan to provide a purpose-built PFA therapy integrated with 3D mapping and navigation.
According to a news release, both teams bring decades of experience in pioneering novel PFA and navigation technologies. Their experiences range across various medical applications.
“PFA has generated much excitement in the treatment of atrial fibrillation due to an improved safety profile and procedural workflow. However, most of the first-generation PFA technologies today are repurposed from other applications and suffer from significant limitations outside a subset of AFib procedures,” said Dr. Steven Mickelsen, CEO of Field Medical. “This collaboration brings together second-generation focal PFA and AI-based cardiac mapping—a combination set to revolutionize catheter ablation across …